326.11
+1.11
(0.34%)
May 24 - Close
LON real-time data - Disclaimer
Currency in GBX unless noted
| Range | 321.59 - 328.00 |
| 52 week | 158.50 - 340.00 |
| Open | 325.00 |
| Vol. | 870,175.00 |
| Mkt cap | 783.32M* |
| P/E | 24.21 |
| Div/yield | 2.21* |
| EPS | 0.13* |
| Shares | 240.20M |
| Beta | - |
| Inst. own | - |
| *GBP |
Events
May 9, 2013
Interim 2013 United Drug Plc Earnings Conference Call
|
|
Key stats and ratios
| Q1 (Mar '13) | 2012 | |
| Net profit margin | 1.29% | 2.60% |
| Operating margin | 2.41% | 3.69% |
| EBITD margin | - | 5.14% |
| Return on average assets | 2.27% | 4.52% |
| Return on average equity | 6.26% | 11.80% |
| Employees | 4,612 | - |
| Carbon Disclosure Rating | - | - |
Address
United Drug House Magna Drive, Citywest Road Magna Business Park, Dublin 24
DUBLIN, 24
Ireland
+353-1-4632300 (Phone)
+353-1-4596893 (Fax)
DUBLIN, 24
Ireland
+353-1-4632300 (Phone)
+353-1-4596893 (Fax)
Website links
External links
Analyst Estimates - BusinessWeek
Options - MarketWatch
Research Reports - Reuters
Director Dealings - Yahoo Finance
Discussion Group - Google Finance
Advertisement
Description
United Drug plc is a provider provides outsourced commercial solutions to international healthcare companies. The Company specialize in supply chain, packaging, sales and marketing, medical and regulatory services. The Company operates through three divisions: Healthcare Supply Chain, Packaging & Specialty, Sales, Marketing & Medical. Sales, Marketing & Medical provides contract sales outsourcing and related marketing and regulatory services to healthcare manufacturers. Healthcare Supply Chain combines all of the Company�s healthcare logistics based businesses. Packaging & Specialty provides outsourced packaging solutions for pharmaceutical manufacturers. On August 20, 2012, the Company confirmed the completion of the acquisition of the United Kingdom and the United States clinical services businesses combined (Bilcare Global Clinical Supplies or Bilcare GCS) from Bilcare Limited.
Officers and directors
| Liam M. FitzGerald | Chief Executive, Executive Director | |
| Chris Corbin | Managing Director - Sales, Marketing & Medical division, Executive Director | |
| Alan Ralph | Chief Financial Officer, Executive Director | |
| Mike Gannon | Company Secretary | |
| Peter Gray | Non-Executive Independent Chairman of the Board | |
| Barry McGrane | Non-Executive Director | |
| Christopher Brinsmead | Non-Executive Independent Director | |
| Hugh Friel | Non-Executive Independent Director | |
| Gary W. McGann | Senior Independent Non-Executive Director |